Novel Topical Formulation That Modulates Nociception Pathways
Patent No. EP3962600 (titled "Novel Topical Formulation That Modulates Nociception Pathways") was filed by Pierre Fabre Dermo Cosmtique on Apr 30, 2020. The application was issued on Nov 19, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3962600
- Application Number
- EP20731913A
- Filing Date
- Apr 30, 2020
- Status
- Granted And Under Opposition
- Oct 17, 2025
- Publication Date
- Nov 19, 2025
- External Links
- Slate, Register , Google Patents